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Electrically pcrmeabilized RINmSF cells were used to study whether galanin inhibits insulin secretion distally to the gen- 
eration of soluble second messengers. CaZ+-’ Induced insulin secretion was inhibited by the neuropeptide in a dose-depen- 
dent manner. Galanin appears to act via a G-protein as pcrsussis toxin treatment abolished the effect. GTP (100 PM), 
GDP (100 PM) and a low dose of GTPyS (10 PM) did not affect galanin-mediated inhibition of secretion. In contrast, 
at 100 pM, GTPyS attenuated and GDP,% abolished the effect of the peptide. We conclude that galanin inhibits exo- 
cytosis directly by a mechanism involving a G-protein. 
Galanin; Insulin secretion; Permeabilization; Pertussis toxin; Guanine nucleotide; (RINmSF cell) 
1. INTRODUCTION 
Galanin, a 29 amino acid neuropeptide, has been 
found to inhibit basal and stimulated insulin secre- 
tion in a variety of systems [1,2]. Immunocyto- 
chemical staining revealed that galanin is present in 
intrapancreatic nerves [3]. The peptide may there- 
fore play an important role in the regulation of 
hormone secretion from pancreatic islets. Galanin 
receptors have been characterized in brain and 
Syrian hamster insulinoma tissue [4,5]. In the 
insulin-secreting cell line RINmSF, galanin inhibits 
insulin release and adenylate cyclase activity, both 
effects being attenuated by pertussis toxin pretreat- 
ment [6]. These properties are also shared by other 
inhibitory hormones, somatostatin and cuz-adrener- 
gic agonists, e.g. epinephrine [7]. Since cyclic AMP 
levels do not correlate with the rate of insulin secre- 
tion, it is unlikely that lowering of cyclic AMP is 
the sole factor mediating the inhibition of secretion 
[g]. It has been found that galanin hyperpolarizes 
RINm5F cells [9,10] and attenuates glucose-in- 
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duced depolarization in islet cells 111,121. The 
changes in membrane potential are due to activa- 
tion of ATP-sensitive K+ channels [9] via a per- 
tussis toxin-sensitive G-protein [lo]. However, 
neither the action on membrane potential nor the 
lowering of cytosolic Ca2+([Caz+]i) [ll, 121 offers 
sufficient explanation for the potent reduction of 
insulin release. To elucidate the action of galanin 
we used permeabilized RINmSF cells, a system in 
which the regulation of cyclic AMP levels and 
[Ca2+]i can be bypassed [13]. We demonstrate that 
galanin inhibits Ca2+ -induced secretion in a dose- 
dependent manner and that pertussis toxin abolis- 
hes the effect. These findings suggest hat galanin 
inhibits exocytosis at a site distal to and indepen- 
dent of the gating of K+ channels and the inhibition 
of adenylate cyclase activity. 
2. MATERIALS AND METHODS 
RINmSF cells were cultured and permeabilized as in [13]. In 
brief, before use, the cells were kept for 3 h in spinner culture. 
Permeabilization by high-voltage discharge (10 exposures to an 
electrical field of 3 kV/cm each of 30 fits duration) was carried 
out in mannitol buffer (pH 7.0), containing 270 mM mannitol, 
10 mM potassium glutamate, 5 mM MgATP, 0.4 mM EGTA, 
20 mM Hepes. Permeabilized cells were incubated in potassium 
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glutamate buffer (pH 7.0), containing 140 mM potassium 
glutamate, 5 mM NaCl, 7 mM MgS04, 5 mM NarATP, 
10.2 mM EGTA and Ca2+ and other test substances at ap- 
propriate concentrations for 15 min at 4°C and subsequently 
for 5 min at 37°C. Incubations were stopped by chilling to 4°C 
followed by centrifugation. The nucleotide triphosphate- 
regenerating system consisting of 21 U/ml of creatine kinase 
and 2 mM phosphocreatine was only added when GTP was pre- 
sent in the incubation medium. Immunoreactive insulin was 
measured in the supernatant as described 1131. Pertussis toxin 
(100 ng/ml) treatment of the cells was carried out during the 3 h 
spinner culture prior to permeabilization. 
GTP, GTPyS, GDP, GDPPS, NazATP and MgATP were 
from Sigma (St. Louis, MO). Galanin was purchased from 
Bachem Bioscience (Bubendorf, Switzerland) and pertussis tox- 
in from List Biological Labs (Campbell, CA). 
3. RESULTS AND DISCUSSION 
Galanin decreases Ca’+-induced insulin secre- 
tion in electrically permeabilized RINmSF cells in a 
dose-dependent manner (fig.1). 10 nM galanin at- 
tenuates insulin secretion by 23070, while the pep- 
tide at 0.1 and 1 PM inhibits secretion by 32 and 
43%) respectively. These galanin concentrations 
are one order of magnitude higher than those 
reported for inhibition of insulin secretion in intact 
isolated islet cells [ 1 l] and in RINmSF cells [6]. 
When RINmSF cells were treated with pertussis 
toxin prior to permeabilization, the inhibitory ef- 
fect of galanin on Ca2+-induced secretion was 
abolished (fig.%). Thus, galanin interference with 
exocytosis may be mediated by a pertussis toxin- 
sensitive G-protein. A previous study suggested 
that pertussis toxin causes ADP-ribosylation of at 
least two protein bands in RINmSF cell membranes 
[ 131, which may represent Gi and G, [ 141. It is of 
interest to compare the effects of galanin to those 
of cuz-adrenergic agonists. The latter compounds 
also inhibit stimulated insulin secretion from 
permeabilized islets [ 15,161 and RINmSF cells [ 171. 
In our previous study [17] several ines of evidence, 
including the abrogation of the inhibition by per- 
tussis toxin, suggest that the inhibition is secondary 
to the coupling of az-adrenoceptors to a G-protein. 
Galanin action, however, is not mediated by 
adrenergic receptors since adrenergic antagonists 
did not attenuate its effects [18]. Such receptors 
have indeed been characterized by 12?-galanin 
binding in rat brain [4] and hamster pancreatic 
tumor cells [5]. 
To substantiate further the involvement of a G- 
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Fig. 1. Concentration dependency of galanin-induced inhibition 
of basal and Ca2+-stimulated insulin secretion in permeabilized 
RINmSF cells. Cells were incubated for 5 min in the presence of 
0.1 pM Ca’+ (open circles) or 10 PM Ca*+ (filled circles) and in- 
creasing amounts of galanin as indicated. 100 PM GTP and a 
nucleotide-regenerating system were present throughout; for 
details see section 2. Secretion at 0.1 pM Ca2+ in the absence of 
galanin was set to 100%. Results are means f SE of 20 observa- 
tions from 4 independent experiments. Statistical analysis was 
by Student’s t-test for unpaired data: * P<O.O5, ** P<O.OOl. 
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Fig.2. Effect of pertussis toxin treatment on galanin-induced in- 
hibition of insulin secretion in permeabilized RINmSF cells. 
Cells were kept 3 h in spinner culture without (control) or with 
pertussis toxin prior to permeabilization as described in section 
2. Incubations were carried out in the presence of 100 PM GTP 
at 0.1 or 10 PM Ca’+. Galanin was used at 0.1 PM (filled bars). 
Results are means + SE of 15 observations from 3 independent 
experiments. * P<O.O5. 
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inhibition upon exogenously added guanine 
nucleotides. The potency of the peptide to inhibit 
Ca’+-induced secretion does not change irrespec- 
tive of whether GTP (IOOpM) is added to the in- 
cubation medium (table 1). This finding differs 
from the inhibitory effect of epinephrine on 
Ca2+-induced insulin secretion which was 
augmented by the addition of GTP up to 500,~M 
u71. 
In the presence of the non-hydrolyzable GTP- 
analog GTPyS (10 PM) galanin is still able to exert 
its inhibitory effect on secretion. In contrast, a 
higher concentration of GTPyS (1OOpM) reduces 
the peptide-mediated inhibition (table 1). As in our 
previous studies [ 13,171 insulin secretion stimu- 
lated with 10 ,uM Ca2+ in the absence of galanin 
was not affected significantly by GTP or GTPyS 
(not shown). These results indicate that galanin, in 
contrast to epinephrine, does not require the 
presence of hydrolyzable GTP, to cause the inhibi- 
tion of insulin secretion. 
In the next series of experiments the importance 
of endogenous GTP was further tested by the addi- 
tion of GDP and its stable analog GDPfiS. These 
nucleotides displace GTP from its protein-binding 
sites. GDP (1OOpM) affects neither Ca2+-induced 
secretion nor the inhibitory effect of galanin 
(fig.3). GDP@ (lOOrM), in agreement with our 
earlier studies [ 13,171, attenuates Ca2+-stimulated 
insulin secretion and abolishes the effect of galanin 
(fig.3). These results demonstrate that the effects 
of GDPflS and galanin on secretion are not ad- 
ditive, perhaps indicating a common site of action 
Table 1 
Effects of guanine nucleotides on galanin-induced inhibition of 
insulin secretion in permeabilized RINmSF cells 
Addition Inhibition (o/o) 
A no guanine nucleotide 29.6 f 6.2 (7) 
B 100 #M GTP 33.9 f 2.7 (7) 
C 10 /M GTPyS 35.4 k 4.6 (7) 
D 100 PM GTPyS 15.0 + 2.5 (3) 
RINmSF cells were permeabilized and incubated as described in 
section 2. Galanin was tested at 0.1 ,uM in the absence or 
presence of GTP plus a regenerating system or GTPyS as in- 
dicated. Results are expressed as % inhibition of insulin secre- 
tion due to increasing Ca *’ from 0.1 to 10 CM in the absence or 
presence of the respective guanine nucleotide. Data are means 
f SE from the given number of independent experiments each 
performed in quintuplet 
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Fig.3. Effect of galanin on Ca*+-induce 
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secretion in the 
presence of GTP, GDP and GDP&L Permeabilized RINmSF 
cells were incubated at 0.1 or 10pM Ca*+ in the presence of 
100 FM GTP and a regenerating system (A), 100 FM GDP (B) 
or 100 FM GDP@S (C) without (open bars) and with 0.1 pM 
galanin (filled bars). Results are means rf: SE of 10 observations 
from 2 separate xperiments. 
for the two substances. In contrast to epinephrine 
inhibition of Ca’+-induced insulin secretion [ 171, 
galanin action is thus not sensitive to blockade of 
GTP-binding sites by GDP. The present findings 
that galanin inhibits Ca2+-stimulated insulin secre- 
tion in permeabilized cells indicate an action ex- 
erted at a point distal to the generation of soluble 
messenger molecules. Thus, in permeabilized cells 
(i) ion channels are short-circuited and the opening 
of K+ channels can be disregarded [9, lo]; (ii) inter- 
ference with Ca2+ handling can be excluded, since 
the Ca2+ concentration is clamped with EGTA; (iii) 
cyclic AMP levels are very low under the ex- 
perimental conditions used [17] and alterations in 
adenylate cyclase activity [6] cannot explain the in- 
hibition of insulin secretion. We describe here that 
the inhibition of Ca2+-stimulated insulin release is 
overcome by pertussis toxin, as is the case for the 
other known actions of galanin, i.e. the opening of 
K+ channels [lo], the lowering of [Ca2+]i [12] and 
the inhibition of adenylate cyclase [6] in intact 
cells. 
The identity of the pertussis toxin-sensitive G- 
protein mediating the galanin effect, as well as the 
mechanism beyond G-protein activation, remain 
unknown. The putative site of action may be a fu- 
sion pore [19,20] formed by oligomerization of a 
specific pore-forming protein in a manner sug- 
gested for exocytosis of synaptic vesicles [21]. It is 
conceivable that complete inhibition of insulin 
secretion is a result of the concerted action of 
galanin on ion channels, adenylate cyclase and the 
direct interference with eoxcytosis. 
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